NCT01766505View on ClinicalTrials.gov

The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR)

PHASE4TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Hypertension
Interventions
DRUG

Candemore tablet

"Candemore tablet 8, 16, or 32mg/tab, per oral, a tablet once a day during 16 weeks.~dosage is depends on the sitting blood pressure."

DRUG

Cozzar tablet

Cozzar tablet: 8mg, 16mg, 32mg/tablet, per oral, a tablet a day during 16 weeks dosage depends on sitting blood pressure

Trial Locations (9)

301-721

Chungnam national university hospital, Daejeon

301-723

The catholic university of Korea, Daejeon st. Mary's Hospital, Daejeon

302-718

Konyang university hospital, Daejeon

302-799

Eulji University Hospital, Daejeon

501-757

Chunnam National University Hospital, Gwangju

503-715

Kwangju Christian Hospital, Gwangju

560-750

Presbyterian Medical Center, Jeonju

561-712

Chunbuk National University Hospital, Jeonju

540-719

ST.Carollo hospital, Suncheon

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY